REHOVOT, Israel, April 7, 2021 /PRNewswire/ — Evogene Ltd. (NASDAQ: EVGN), (TASE: EVGN), a leading computational biology company today announced that it will hold virtual investor and analyst days, in both Hebrew and English, via Zoom webinars.
The meetings will feature key-note presentations from Evogene’s CEO, Ofer Haviv, and the CEOs of Evogene group subsidiaries Biomica, Canonic, AgPlenus, and Lavie Bio, followed by a question and answer session.
Questions to the speakers may be sent in advance of the event via the registration link or to [email protected] or may be sent via the Question and Answer link in the zoom webinar during the event.
About Evogene Ltd.:
Evogene (NASDAQ: EVGN), (TASE: EVGN) is a leading computational biology company focused on revolutionizing product discovery and development in multiple life-science based industries, including human health and agriculture, through the use of its broadly applicable Computational Predictive Biology (CPB) platform. The CPB platform, incorporating a deep understanding of biology leveraged through the power of Big Data and Artificial Intelligence, has been designed to computationally discover and uniquely guide the development of life-science products based on microbes, small molecules and genetic elements. Utilizing the CPB platform, Evogene and its subsidiaries are now advancing product pipelines for human microbiome-based therapeutics through Biomica Ltd., medical cannabis through Canonic Ltd., ag-biologicals through Lavie Bio Ltd., ag-chemicals through AgPlenus Ltd., and ag-solutions for castor oil production through Casterra Ltd.
|
Evogene Investor Contact: |
US Investor Relations: |
|
Rivka Neufeld / Aviva Banczewski |
Joseph Green |
|
Investor Relations |
Edison Group |
|
T: +972-8-931-1900 |
T: +1 646-653-7030 |
|
Laine Yonker |
|
|
Edison Group |
|
|
T: +1 646-653-7035 |
SOURCE Evogene
